VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
AARD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
AARDAardvark Therapeutics, Inc. Common Stock
$1.45$30M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAARDQuarterly Balance Sheet

Aardvark Therapeutics, Inc. Common Stock (AARD) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Aardvark Therapeutics, Inc. Common Stock (AARD) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

AARD Balance Sheet

Quarterly statement

AARD Balance Sheet

Aardvark Therapeutics, Inc. Common Stock (AARD) balance sheet — 4-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Total Current Assets80.66M93.58M111.89M129.21M144.77M154.55M74.14M82.67M86.99M010.37M
Cash & Short-Term Investments73.87M91.2M110.03M126.35M141.82M151.26M73.66M82.36M86.35M09.99M
Cash Only73.85M62.44M47.05M39.28M26M26.5M61.64M82.28M86.17M09.73M
Short-Term Investments21K28.76M62.98M87.06M115.82M124.76M12.02M83K174K0254K
Accounts Receivable00000000000
Days Sales Outstanding-----------
Inventory00000000000
Days Inventory Outstanding-----------
Other Current Assets6.79M2.38M1.86M2.86M2.95M3.29M160K136K197K0127K
Total Non-Current Assets799K5.01M5.29M4.02M2.71M2.47M3.37M1.07M213K0168K
Property, Plant & Equipment626K269K355K439K522K628K735K841K105K0155K
Fixed Asset Turnover-----------
Goodwill00000000000
Intangible Assets00000000000
Long-Term Investments00000000000
Other Non-Current Assets173K4.74M4.94M3.58M2.19M1.84M2.63M232K108K013K
Total Assets81.46M98.59M117.18M133.23M147.47M157.03M77.51M83.74M87.2M010.54M
Asset Turnover-----------
Asset Growth %-44.76%-37.21%51.19%59.1%69.12%-635.64%----
Total Current Liabilities6.39M11.6M10.55M10.74M10.31M5.98M4.93M2.61M2.66M01.38M
Accounts Payable2.09M4.49M2.07M4.44M5.06M2.56M2.3M666K1.22M01.03M
Days Payables Outstanding-----------
Short-Term Debt401K0441K00000000
Deferred Revenue (Current)00000000000
Other Current Liabilities3.9M1.52M5.12M2.15M1.38M498K896K620K933K045K
Current Ratio12.63x8.06x10.61x12.03x14.04x25.86x15.05x31.65x32.67x-7.50x
Quick Ratio12.63x8.06x10.61x12.03x14.04x25.86x15.05x31.65x32.67x-7.50x
Cash Conversion Cycle-----------
Total Non-Current Liabilities276K00116K240K360K127.22M127.3M126.84M043.96M
Long-Term Debt276K0000000000
Capital Lease Obligations000116K228K336K441K545K0050K
Deferred Tax Liabilities00000000000
Other Non-Current Liabilities000012K24K126.78M126.76M126.84M043.91M
Total Liabilities6.66M11.6M10.55M10.85M10.55M6.34M132.15M129.91M129.51M045.34M
Total Debt677K336K441K545K645K726K779K868K108K0162K
Net Debt-73.17M-62.1M-46.61M-38.74M-25.35M-25.78M-60.86M-81.41M-86.06M0-9.57M
Debt / Equity0.01x0.00x0.00x0.00x0.00x0.00x-----
Debt / EBITDA-----------
Net Debt / EBITDA-----------
Interest Coverage-----------
Total Equity74.8M86.99M106.63M122.38M136.93M150.69M-54.64M-46.17M-42.31M0-34.8M
Equity Growth %-45.37%-42.27%295.14%365.03%423.65%--57.01%----
Book Value per Share3.423.994.895.636.316.95-2.52-2.16-1.98--1.63
Total Shareholders' Equity74.8M86.99M106.63M122.38M136.93M150.69M-54.64M-46.17M-42.31M0-34.8M
Common Stock00000000000
Retained Earnings-151.89M-137.51M-115.92M-98.32M-82M-67.64M-58.33M-49.55M-45.37M0-37.74M
Treasury Stock00000000000
Accumulated OCI014K81K82K-3K44K00000
Minority Interest00000000000